Home News Breaking News Briefs

Breaking News Briefs

Summaries of current approvals by global regulatory agencies of drugs and other treatment-related therapeutic agents used to treat lung cancer and other thoracic neoplasms.

Breaking News Briefs

European Medicines Agency Approves Lorlatinib March 1, 2019—The EMA has endorsed lorlatinib for the treatment of patients with ALK-positive advanced NSCLC that has progressed during prior...

Meeting News